Dominiki Kati

She is an experienced Life Sciences professional with significant exposure in the biotechnological and pharmaceutical industry for the past 6 years.


Ms. Kati has a rich academic background in Molecular Biology working in various research projects across different countries since 2012.


In 2015 she completed her Master of Science in Pharmaceutical Science with Distinction at Edinburgh Napier University, and shortly after graduating she began my career in R&D in Scotland, UK. She gained experience in leading and planning development activities and familiarized herself with validation requirements for in vitro diagnostics.


Her focus was the technical transfer of processes from development to production in Switzerland.

In 2019 she worked in Medical and Commercial operations for a startup pharmaceutical services company in Dubai, UAE, having broad set of responsibilities across all business functions including medical and regulatory affairs.


In 2020, she started my journey in Pharmacovigilance with Genpharm Services, supporting the rare disease community in the MENA region.


She is currently managing all pharmacovigilance activities in the region; she is responsible for the development and implementation of the internal Pharmacovigilance system, and    she is acting as the Pharmacovigilance Officer for all safety reporting and monitoring.

Topic of Submission

Supporting the rare disease community in the MENA region


Eman Gomaa

Eman has a wealth of experience in PV since 2012; with a strong network with decision makers in different health authorities. She held several senior roles in multiple multinational Pharma companies.

She started her PV career in Cairo, in 2012, at the very early beginnings of the Egyptian PV guidelines followed by the Arab GVP implementation in 2015.

She has worked in multiple pharmaceutical companies, from local Egyptian companies to Gilead’s agent in Cairo then joined Allergan as Egypt LSO in March 2016. After one year, she was selected to the Regional PV Lead for TMEA region in March 2017 and relocated to Dubai in Dec 2017.

After Abbvie’s acquisition of Allergan in May 2020, Eman supported the global and affiliate PV integration workstreams and subsequently was appointed on May 2021 as the Lead of the Middle East & Africa PV hub , the largest PV hub in Abbvie.

She also has a vast experience in delivering trainings to multiple pharmaceutical companies in Egypt on Arab GVP and her trainings were accredited and acknowledged by the Head of Egyptian Pharmaceutical Vigilance Center in Egypt.

Lastly, Eman has participated in GCC PV trainings that took place in Dubai, UAE, in years 2019 and 2020, 2021 and her sessions were widely recognized and got excellent feedback from the audience and regulators as well.

She also has multiple lectures in the annual PV course arranged by PRA and the Dubai Pharmacy College since 2020.

Eman is now the Middle East & Africa MEA Hub Lead in Abbvie and also is a member of International Society of Pharmacovigilance ISoP, ISoP Middle East Chapter and the Country Representative in United Arab Emirates.

Topic of Submission

Creating the MEA PV Hub


Hayet Zouzou

Hayet Zouzou is currently Pharmacovigilance Country Cluster Lead for EEMEA region at Roche based in Dubai

Hayet studied a pre-Pharmacy course at Toronto University in Canada and she possess a Master of Pharmacy Degree from Nottingham University in the United Kingdom.

Hayet has experience in community Pharmacy (Boots) and in different departments in Barnsley hospital and Cambridge university hospital NHS trust in the UK. This includes Oncology; ICU; Medical information and Pharmacovigilance department…to name a few.

She has an experience is Pharmacovigilance, clinical trials, and risk management

Hayet possess the genuine drive and commitment to train, lead, set strategies to optimize Pharmacovigilance practice; simplify and improve both the operational and talent development processes and practices, set up a strong communication program, and ensure compliance to local and global regulations.

She is eager to work hand in hand with internal stakeholders and external organizations to continue the journey towards boosting Pharmacovigilance knowledge, leading patient centric initiatives and support enabling access to treatments putting the patients in the heart of each success and making a difference to their lives


Topic of Submission

Pharmacovigilance Patient Centric Success stories


Joëlle Issa-Blok

Joëlle Issa-Blok works at Acino MEA, UAE as Regulatory Affairs, Quality and Pharmacovigilance Director for the Middle East, Turkey and Africa region. She has 16 years’ experience in the pharmaceutical industry in different positions, starting in Regulatory Affairs Europe R&D in the Netherlands, then in various regional roles as Head of Regulatory Affairs and Pharmacovigilance MEA where she has been building and leading different Regulatory Affairs, Pharmacovigilance teams and organizations. Joëlle is a Pharmacist, in addition she holds a MSc degree in Drug Innovation R&D from the University of Utrecht in the Netherlands.


Topic of Submission

Establishment of a compliant PV system